Michael D. Mulholland
2016 - CytoDyn
In 2016, Michael D. Mulholland earned a total compensation of $838.1K as Chief Financial Officer at CytoDyn, a 99% increase compared to previous year.
Compensation breakdown
| Bonus | $152,750 |
|---|---|
| Option Awards | $414,932 |
| Salary | $262,500 |
| Other | $7,875 |
| Total | $838,057 |
Mulholland received $414.9K in option awards, accounting for 50% of the total pay in 2016.
Mulholland also received $152.8K in bonus, $262.5K in salary and $7.9K in other compensation.
Rankings
In 2016, Michael D. Mulholland's compensation ranked 9,084th out of 14,075 executives tracked by ExecPay. In other words, Mulholland earned more than 35.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,084 out of 14,075 | 36th |
Division Manufacturing | 3,513 out of 5,489 | 36th |
Major group Chemicals And Allied Products | 1,207 out of 1,895 | 36th |
Industry group Drugs | 955 out of 1,538 | 38th |
Industry Pharmaceutical Preparations | 759 out of 1,176 | 36th |
Source: SEC filing on July 24, 2017.
Mulholland's colleagues
We found one more compensation record of an executive who worked with Michael D. Mulholland at CytoDyn in 2016.
2016
Nader Pourhassan
CytoDyn